After completing his medical studies and a Master’s Degree in Pharmacology in South Africa, Danie spent 3 years working in a primary care setting including his own private practice. He joined the pharmaceutical industry in 1993, worked in Medical Affairs, Marketing, Pharmacovigilance and Clinical Operations. He held roles of increasing responsibility and leadership, including Senior Vice President and Head of Worldwide Medical Affairs at GlaxoSmithKline. In 2019, Danie joined Kyowa Kirin International as the Executive Vice President for Medical Affairs, a role which he held until recently.

He is registered with the medical councils in the UK and South Africa and completed his MBA through Heriot Watt University and Edinburgh Business School in 2006. He is a Board Chair of the Medical Affairs Professional Society (MAPS) Board, and an affiliate member of the Association for Professional Executive Coaching and Supervision (APECS).

Dr. Nadia Hergli is the Head of Medical Affairs - International at Chiesi Global Rare Disease, based in Brussels, Belgium. She joined Chiesi in early 2024 following the acquisition of Amryt Pharma, where she spent six years. In her current role, Dr. Hergli leads Medical Affairs across Distributor Markets, including the Middle East, Africa, Asia Pacific, Australia, and Japan, with a dedicated focus on rare diseases and orphan drugs.

With over 23 years of experience in the pharmaceutical industry, Dr. Hergli began her career as a clinical research coordinator at the Ministry of Scientific Research & Technology in Tunisia, focusing on epidemiological studies of preventable diseases. A physician by training, she graduated from the University of Medicine of Monastir in Tunisia. She entered the pharmaceutical sector in 2002 at Sanofi and subsequently moved to GlaxoSmithKline in 2003, where she spent over 16 years in roles of increasing responsibility, specializing in medical affairs and scientific communication for vaccines and rare diseases at both regional and global levels.

Dr. Hergli’s career has been defined by a commitment to advancing healthcare access and improving patient outcomes, particularly through life-changing therapies and vaccines. She has co-authored numerous scientific publications on rare diseases, vaccines, and public health and continues to drive initiatives in medical education and evidence generation

Following Graduation in Medicine at the Free University Berlin, Michael pursued a career in General, Cardiovascular and Surgical Oncology in Germany and the UK, gaining an MD and an FRCS.  He joined pharmaceutical industry 25 years ago and has since been in clinical development, project leadership, and commercial and medical affairs roles at country, regional and global level. To date, Michael leads the Medical Affairs Team of Novartis Oncology, Region Europe.
Throughout his industry career, Michael mainly covered specialty care areas, e.g. Oncology and Immunology. He also qualified as a Pharmaceutical Physician and as an MBA. Research interests and publications are in Oncology and Immunology as well as in general aspects concerning Medical Affairs and Medicine Development in the Industry.

Zhen is a pharmacist by background being in the pharmaceutical industry over 15 years. She has worked in many different medical functional and medical affairs roles covering country, regional and international roles and she has worked in different medicines categories from consumer, medical devices to pharmaceutical medicines. In recent years she has been focused on rare diseases and working on pre-launch and launch. In late 2024, she moved to a commercial role as Head of DEE & Epilepsy at UCB.

After receiving his Ph.D. in Biochemistry from the University of Münster, Germany, Christian spent 3 years as Postdoc at the University of Madison Wisconsin, USA. After a second Postdoc position in Würzburg, Germany, he moved to a role as Senior Scientist at the immunology research and development department at Merck Serono in Geneva, Switzerland and later at EMD Serono in Boston, MA,  USA. Christian changed into Medical Affairs as an MSL for Vaccines in Pfizer, Switzerland and later worked as Medical Affairs Manager at Celgene and gained responsibility for the European MSL team at Sunovion Pharmaceuticals Europe.

Today Christian is leading the Medical Affairs anti-infectives department at Tillotts Pharma AG, in Rheinfelden, Switzerland including the European MSL team.

Alan qualified in medicine in 1984 from the University of Glasgow in Scotland.  He trained as a family doctor (GP) and worked in and around Glasgow for 14 years in the health service until leaving to join Novo Nordisk in 1998.

After leadership positions with both Novo Nordisk, BioMarin Europe and AstraZeneca, Alan joined Astellas as their UK Medical Director in 2009 before moving to a sub-regional European role in 2014.

In late 2016 he relocated to Singapore to become Head of Medical Affairs for Asia-Oceania and in 2020 his territories expanded to include Latin America, Middle East, Africa, Russia and Turkey.

In July 2021 Alan transferred back to the UK to lead medical affairs for Europe and Canada.

Alan is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians (UK). Alan led a global medical affairs capability uplift programme at Astellas, he has a passion for leadership and team development and the ethics of pharmaceutical medicine.

Natasha Hansjee, PhD, is a global principal scientific communication director at Roche. She is also  an executive coach and a storyteller. She has over 20 years of pharmaceutical marketing experience: sales, local & global strategic product management; global product commercial strategy training; scientific communications; mentoring, coaching and facilitating - and has worked across all stages of the life cycle (early launch, launch, LoE). 

Troels Sørensen has over 25 years of experience in the pharmaceutical industry with a unique broad profile across gene therapy, biologic, and small molecule specialty care, executing customer-facing and leadership roles in Research, Clinical Operations, Medical Affairs, Sales, Marketing and Commercial Asset/Portfolio evaluation.

His passion is equitable population health attainment through the integration of public and private sectors of health systems by the development of common language, measures, and goals along the tactic to impact continuum. He devised the Target Population Output (TPO) measurement, a common tool for public and private stakeholders to align population health and business goals. TPOs have been implemented and refined since 2020. In 2023 TPOs were introduced publicly in the context of the Harvard Health System Innovation Lab’s Strategic Public Private Partnership (SPPP) framework, and in 2024 this was presented, by Harvard, at the World Economic Forum, Davos, in a session hosted by them, Novartis and Novo Nordisk.

As Global Head of Clinical Practice at Boehringer-Ingelheim, Troels leads Global Medical Affairs Partnerships, Implementation Science and TPO teams. Troels continues to work on practical and pragmatic solutions for alignment and goal setting within the pharmaceutical industry to facilitate partnership and integration with health systems.

Based in Basel, Switzerland, Troels, has worked for several pharmaceutical companies including Roche, Johnson & Johnson, UCB, AstraZeneca, Takeda, and Novartis. He is an alumnus of the European Schools System, Oxford University, the British Medical Research Councils’ National Institute for Medical Research (now The Francis Crick Institute) and Warwick Business School.

Mike Taylor is Head of Metrics at Digital Science, where he specialises in quantitative and qualitative analyses of academic trends using Dimensions, Altmetric and other data sources. Before joining Digital Science, Mike spent many years working in Elsevier’s R&D group and in the Metrics and Analytics Team.  He works with many community groups, including FORCE11, RDA and NISO, and is well known in the scholarly metrics community. It was his love of books that originally attracted him to publishing, and this continues to fuel his enthusiasm for books as a key part of the scholarly record. He is on twitter @herrison.

Chris Bassett is Sales Director for UK and Northern Europe at Springer Healthcare (part of the Springer Nature group).  Based in the UK, Chris started his Springer career as Commercial Partnership Manager, managing Springer’s relationships with key society and content stakeholders, such as ASCO and ASH.  In recent years, Chris has developed and now leads an expert team of educational content developers, delivering a wide range of solutions for healthcare professionals.   From in-person expert meetings and traditional print tools, through to interactive learning modules, live and on-demand webinars, and harnessing the power of digital opinion leaders.  Chris’s expertise lie in identifying the optimal content, delivered in the best format, to enact positive change for the healthcare industry.

Aaron specialises in developing unified omnichannel experiences within the pharmaceutical industry, leveraging emerging technology to automate processes, enhance customer experience, and generate actionable insights. Collaborating with cross-functional teams, Aaron builds cohesive strategies that connect across various touchpoints, ensuring consistent messaging. Aaron champions data and personalisation principles that enable a holistic view of customer beliefs and behaviours, allowing for highly targeted and relevant experiences.

Michelle is a Client Services Director at Springer Healthcare (part of the Springer Nature Group) and has 25 years' experience delivering and leading medical communication programmes.

Michelle enjoys strategic planning and delivery but a focus, and a core skill, is building relationships with stakeholders (externally and internally) to refine team skills and dynamics and enhance communications and performance. The result being, ultimately, to increase effectiveness and efficiencies for all parties.

Michelle is qualified in Business, Finance, Law, and Marketing and has a background in sales and creative design.

Caroline Phillips is Vice President of Medical Affairs at Medscape, with over 25 years of experience in the pharmaceutical industry. Medscape Medical Affairs specialises in the translation of clinical science through effective medical communications to enhance patient care. With a background in pharma, medical publishing and CME, Caroline brings a broad perspective to conversations in medical affairs and a strong desire to optimise effectiveness in medical education, delivering programs that are guaranteed to engage the right HCP targets, with measurable impact. 

Luke Rogers is the Senior Director of Business Partnerships at Within3. Luke's background includes degrees in Business, Science & a Masters' in Health Economics. He's worked for almost 15 years in Life Sciences in Live Events, including Running & Moderating Advisory Boards, Investigator Meetings, Payer Panels & Large Congresses. Luke's role is to assist Life Sciences clients of all sizes and scopes to operationalize their digital strategy, particularly around Stakeholder Engagement.

Helen is the Founder and CEO of One MSL, a specialist training provider and consultancy, with a specific focus on the Field Medical function. One MSL was built on a heritage of relevant industry experience: Novartis, Roche & Celgene and Helen’s tenure as Chair for the Medical Science Liaison Professional Association.

One MSL was created from a vision to drive standards of Field Medical excellence, and to maximise the ability of Field Medical colleagues to positively impact current and future patient outcomes through internal collaboration and external engagement.

One MSL is a trusted global solution provider. To date we have partnered with 40+ companies and trained more than 10 000 colleagues, across time zones and in multiple languages, through both live and virtual events.

One MSL is proud of its deep connections within the Field Medical community through LinkedIn (27K followers), surveys, webinars and podcasts.

Helen is motivated to make a difference within the evolving world of Medical Affairs. She is a consultant,  author, mentor, coach and trainer. She welcomes the opportunity to be a keynote speaker to inspire and reassure.  

Mikko is Senior Director, Integrated Communications Strategy at Prime, a trusted, world-leading partner in life science communications, engagement and value optimization for the bio‑pharmaceutical industry. In his role, Mikko partners with pharma and biotech companies to design innovative strategic engagement programmes that drive clinical behaviour change, primarily under a Medical Affairs remit. He has worked across multiple therapy areas, with particular experience in oncology, rare diseases, and neurology, across Global, Regional, and Local levels – including a stint in Pfizer’s Rare Diseases business. Mikko holds an Executive MBA from Cranfield School of Management.

Kevin Dolgin is the co-founder of Observia, a French company specializing in patient support services.  He has worked in healthcare since 1992, in over sixty countries.  Kevin is also an Affilliate Professor at the University of Paris (IAE – Paris I, Panthéon-Sorbonne).  He has been widely published in both trade and scientific publications around the world, and has spoken at, and chaired, numerous trade and academic conferences in healthcare.  Kevin has a BA in economics from Fordham University, an MBA from INSEAD and a Master of Research from the Sorbonne.  He is currently completing his PhD at Saclay University, France.